The Influence of Select Medications on Prospective Hemorrhage Risk in Patients with Spinal or Cerebral Cavernous Malformations

Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations

(2021) Joppe Oldenburg et al.   STROKE

Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial

(2020) Silvia Lanfranconi et al.   Trials

Cerebral Cavernous Malformation: What a Practicing Clinician Should Know

(2020) Kelly D. Flemming et al.   MAYO CLINIC PROCEEDINGS

In Reply to the Letter to the Editor Regarding “Propranolol Treatment of Cavernous Malformations with Symptomatic Hemorrhage”

(2020) Joseph M. Zabramski   World Neurosurgery

Could propranolol be beneficial in adult cerebral cavernous malformations?

(2019) Caroline Apra et al.   NEUROSURGICAL REVIEW

Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease

(2019) Robert Shenkar et al.   STROKE

Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis

(2019) Susanna M Zuurbier et al.   LANCET NEUROLOGY

Symptomatic Hemorrhage From Cerebral Cavernous Malformations: Evidence from a Cohort Study

(2019) Santiago Gomez-Paz et al.   World Neurosurgery

Clinical Management of Bleeding Risk With Antidepressants

(2018) Alexandra L. Bixby et al.   ANNALS OF PHARMACOTHERAPY

Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial

(2018) Sean P Polster et al.   NEUROSURGERY

Anti-Inflammatory Effects of Omega-3 Fatty Acids in the Brain: Physiological Mechanisms and Relevance to Pharmacology

(2017) Sophie Layé et al.   PHARMACOLOGICAL REVIEWS

Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease

(2016) Romuald Girard et al.   Biomarkers in Medicine

Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin

(2016) Saverio Francesco Retta et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Propranolol stops progressive multiple cerebral cavernoma in an adult patient

(2016) Matthias Reinhard et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data

(2016) Margaret A Horne et al.   LANCET NEUROLOGY

Propranolol Treatment of Cavernous Malformations with Symptomatic Hemorrhage

(2016) Joseph M. Zabramski et al.   World Neurosurgery

Propranolol for Cerebral Cavernous Angiomatosis

(2013) Irene Berti et al.   CLINICAL PEDIATRICS

Prospective hemorrhage risk of intracerebral cavernous malformations

(2012) K. D. Flemming et al.   NEUROLOGY

Selective serotonin reuptake inhibitors and brain hemorrhage: A meta-analysis

(2012) D. G. Hackam et al.   NEUROLOGY

Antithrombotic Therapy and Bleeding Risk in a Prospective Cohort Study of Patients With Cerebral Cavernous Malformations

(2012) Hans-Martin Schneble et al.   STROKE

Medication History Taking in Emergency Department Triage Is Inaccurate and Incomplete

(2010) Maryann Mazer et al.   ACADEMIC EMERGENCY MEDICINE

Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity

(2010) Rebecca A. Stockton et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Beliefs of Ambulatory Care Physicians about Accuracy of Patient Medication Records and Technology-Enhanced Solutions to Improve Accuracy

(2010) Douglas L. Weeks et al.   Journal for Healthcare Quality

Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect

(2008) Chae-Moon Lim et al.   JOURNAL OF NEUROSCIENCE RESEARCH